Panelists discuss how metastatic castration-sensitive prostate cancer (mCSPC) is managed with a combination of androgen deprivation therapy, chemotherapy, and novel agents like such as abiraterone and ...

"I'm hopeful that the decisions are more informed in terms of actual science," says Daniel Kwon, MD. In this video, Daniel Kwon, MD, discusses the impact of the JNCI Cancer Spectrum paper, “Germline ...

Mindfulness principles, such as intentionality and presence, can enhance surgeons' well-being and career longevity, addressing high burnout rates. Mindfulness is not a cure-all but helps mitigate ...

Epigenomic cfDNA profiling may predict PSMA expression and response to Lutetium-PSMA in mCRPC patients, offering a non-invasive alternative to PSMA-PET scans. The study showed comparable hazard ratios ...

UGN-101 demonstrated a median duration of response of 47.8 months in patients with low-grade UTUC achieving complete response. The OLYMPUS trial emphasized kidney-sparing techniques, with 75% of ...

“I think as urologists, we need to become more comfortable with the female pelvic floor,” says Ava Saidian, MD. In this video, Ava Saidian, MD, highlights the importance of preventing pelvic prolapse ...

In this video, Jason M. Hafron, MD, explains how PSMA-PET has enabled the use of more targeted treatment approaches in the management of oligometastatic prostate cancer. Hafron is the chief medical ...

Kiwi extract, a natural collagenase, offers a medium-effect therapy with fewer side effects compared to Xiaflex. Peptides show potential as collagenase agents, but their safety profile is currently ...

In this video, Tim A. Richardson, MD, shares his thoughts on the need for more genetic testing in prostate cancer as more targeted therapies become available. Richardson is the director of the ...

GET improves emotional and psychological outcomes in young Latino testicular cancer survivors, reducing anxiety and depressive symptoms. Significant improvements in goal navigation, goal blockage, and ...

Capivasertib with abiraterone and ADT significantly extended rPFS in PTEN-deficient mHSPC patients compared to placebo in the CAPItello-281 trial. The trial showed a trend toward improved overall ...

Patient-reported outcomes are crucial in evaluating the success of treatments for stress urinary incontinence in men. The artificial urinary sphincter significantly improves emotional health, reducing ...